A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma

Fatma E. El-Khouly*, Sophie E.M. Veldhuijzen van Zanten, Marc H.A. Jansen, Dewi P. Bakker, Esther Sanchez Aliaga, N. Harry Hendrikse, W. Peter Vandertop, Dannis G. van Vuurden, Gertjan J.L. Kaspers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
32 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science